{"id":"vindesin","rwe":[],"tags":[],"phase":"discontinued","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"discontinued","trials":["NCT00554164","NCT00135499","NCT00002531","NCT00136565","NCT06739265","NCT02881086","NCT04026269","NCT02845882","NCT05557110","NCT04221035","NCT00002887","NCT05809180","NCT03042429","NCT00003209","NCT05900765","NCT00526318","NCT00430118","NCT00002823","NCT02767674","NCT00764907","NCT06486337","NCT01528085","NCT03631862","NCT04043494","NCT04843267","NCT04152577","NCT00017225","NCT00696735","NCT06918015","NCT00002532","NCT05933967","NCT05290090","NCT00002802","NCT01724879","NCT05498259","NCT05040555","NCT00613457","NCT02987244","NCT00003240","NCT01173887","NCT06176027","NCT02867566","NCT06361329","NCT04899570","NCT05164770","NCT00410631","NCT00144053","NCT00869284","NCT01156883","NCT01117441"],"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"aiSummary":"","brandName":"Vindesin","companyId":"the-lymphoma-academic-research-organisation","ecosystem":[],"mechanism":{"target":"Cytochrome P450 3A4","novelty":"","modality":"Small molecule","drugClass":"","explanation":"","oneSentence":"","technicalDetail":""},"commercial":null,"references":[],"biosimilars":[],"companyName":"The Lymphoma Academic Research Organisation","competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"},{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"Vindesin","indications":{"approved":[{"name":"Acute lymphoid leukemia","diseaseId":"acute-lymphoid-leukemia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Chronic myeloid leukemia","diseaseId":"chronic-myeloid-leukemia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Malignant melanoma","diseaseId":"malignant-melanoma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Malignant tumor of lung","diseaseId":"malignant-tumor-of-lung","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT00554164","phase":"Phase 3","title":"Positron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's Lymphomas","status":"COMPLETED","sponsor":"University Hospital, Essen","isPivotal":true,"enrollment":1073,"indication":"Lymphoma, High-grade","completionDate":"2017-03"},{"nctId":"NCT00135499","phase":"Phase 3","title":"Randomized Study of ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Non Previously Treated Patients Aged From 60 to 65 Years With Diffuse Large B-Cell Lymphoma","status":"TERMINATED","sponsor":"Lymphoma Study Association","isPivotal":true,"enrollment":138,"indication":"Lymphoma, Large-Cell, Diffuse","completionDate":"2010-04-27"},{"nctId":"NCT00002531","phase":"Phase 2","title":"MULTICENTRE TRIAL OF INTENSIFIED THERAPY FOR ADULT ALL (O5/93)","status":"UNKNOWN","sponsor":"Johann Wolfgang Goethe University Hospital","isPivotal":false,"enrollment":0,"indication":"Leukemia","completionDate":""},{"nctId":"NCT00136565","phase":"Phase 2","title":"A Phase II Study Evaluating the Efficacy and Safety of Bortezomib (Velcade™) Combined With ACVBP Regimen in Patients With Previously Untreated Peripheral T-cell Lymphoma","status":"COMPLETED","sponsor":"Lymphoma Study Association","isPivotal":false,"enrollment":60,"indication":"Peripheral T-cell Lymphoma","completionDate":"2011-04-18"},{"nctId":"NCT06739265","phase":"Phase 1","title":"A Phase I/II Study of Golidocitinib in Combination with CHOP in Patients with Newly Diagnosed Peripheral T Cell Lymphoma","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","isPivotal":false,"enrollment":68,"indication":"Peripheral T-cell Lymphoma","completionDate":"2027-09-01"},{"nctId":"NCT02881086","phase":"Phase 3","title":"Treatment Optimization in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment - a Phase IV-trial With","status":"COMPLETED","sponsor":"Goethe University","isPivotal":true,"enrollment":1023,"indication":"Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma","completionDate":"2024-12"},{"nctId":"NCT04026269","phase":"Phase 1","title":"Clinical Efficacy of MOAP Regimen for Relapsed/Refractory Classical Hodgkin's Lymphoma as a Rescue Therapy After Ineffective Treatment of Additional Low-dose Decitabine to Anti-PD-1 Antibody Camrelizu","status":"UNKNOWN","sponsor":"Han weidong","isPivotal":false,"enrollment":30,"indication":"Hodgkin Lymphoma","completionDate":"2020-12-31"},{"nctId":"NCT02845882","phase":"Phase 3","title":"Modified BFM (Berlin-Frankfurt-Munster)Backbone Therapy for Chinese Children or Adolescents With Newly Diagnosed Lymphoblastic Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Cancer Group, China","isPivotal":true,"enrollment":150,"indication":"Lymphoblastic Lymphoma","completionDate":"2031-12"},{"nctId":"NCT05557110","phase":"Phase 2","title":"A Multicenter, Single-arm, Open-end Study of Reduced-dose Chemotherapy Followed by Blinatumomab in Induction Therapy of Newly Diagnosed Non-elderly Philadelphia Chromosome Negative Acute B Lymphoblast","status":"COMPLETED","sponsor":"Chen Suning","isPivotal":false,"enrollment":35,"indication":"B Acute Lymphoblastic Leukemia","completionDate":"2024-03-31"},{"nctId":"NCT04221035","phase":"Phase 3","title":"High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)","status":"RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","isPivotal":true,"enrollment":800,"indication":"High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy","completionDate":"2032-11"},{"nctId":"NCT00002887","phase":"Phase 1","title":"PHASE I TRIAL OF HYDROXYUREA FOR SALVAGE OF INCURABLE NON-SMALL CELL LUNG CANCER","status":"UNKNOWN","sponsor":"Ottawa Regional Cancer Centre","isPivotal":false,"enrollment":30,"indication":"Lung Cancer","completionDate":""},{"nctId":"NCT05809180","phase":"NA","title":"Prospective Exploratory Clinical Study of Orelabrutinib, Pomalidomide, Rituximab Combined With miniCHOP-like Regimen in Treatment-naive Elderly Patients With DLBCL","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","isPivotal":false,"enrollment":35,"indication":"Diffuse Large B Cell Lymphoma","completionDate":"2026-07-03"},{"nctId":"NCT03042429","phase":"Phase 3","title":"Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-risk Neuroblastoma","status":"COMPLETED","sponsor":"University of Cologne","isPivotal":true,"enrollment":360,"indication":"Neuroblastoma","completionDate":"2016-12-31"},{"nctId":"NCT00003209","phase":"Phase 3","title":"A Randomized Phase III Study of Chemotherapy and Radiotherapy Versus Radiotherapy Alone as Adjuvant Treatment to Patients With Node Positive Stages IB or IIA Cervix Cancer","status":"COMPLETED","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","isPivotal":true,"enrollment":700,"indication":"Cervical Cancer","completionDate":""},{"nctId":"NCT05900765","phase":"Phase 2","title":"A Multicenter, Open-label Phase II Study on the Treatment of Newly Diagnosed Early-stage Hodgkin's Lymphoma With Zimberelimab (GLS-010) Combined With AVD Regimen (Doxorubicin, Vindesine, Dacarbazine) ","status":"RECRUITING","sponsor":"Sun Yat-sen University","isPivotal":false,"enrollment":54,"indication":"Classical Hodgkin Lymphoma","completionDate":"2026-06-30"},{"nctId":"NCT00526318","phase":"NA","title":"Trial Protocol for the Treatment of Children With High Risk Neuroblastoma (NB2004-HR)","status":"UNKNOWN","sponsor":"German Society for Pediatric Oncology and Hematology GPOH gGmbH","isPivotal":false,"enrollment":360,"indication":"Neuroblastoma","completionDate":""},{"nctId":"NCT00430118","phase":"Phase 3","title":"ALL-BFM 2000 Multi-Center Study for the Treatment of Children and Adolescents With Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"University Hospital Schleswig-Holstein","isPivotal":true,"enrollment":4559,"indication":"Leukemia","completionDate":"2012-01"},{"nctId":"NCT00002823","phase":"Phase 3","title":"A LARGE-SCALE TRIAL EVALUATING ADJUVANT CHEMOTHERAPY AFTER CURATIVE RESECTION OF NON-SMALL CELL LUNG CANCER","status":"COMPLETED","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","isPivotal":true,"enrollment":3300,"indication":"Lung Cancer","completionDate":""},{"nctId":"NCT02767674","phase":"Phase 3","title":"Phase III,Randomized Controlled Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma","status":"UNKNOWN","sponsor":"The First Affiliated Hospital with Nanjing Medical University","isPivotal":true,"enrollment":258,"indication":"Diffuse Large B Cell Lymphoma","completionDate":"2020-12"},{"nctId":"NCT00764907","phase":"Phase 3","title":"A Randomized Trial of the I-BFM-SG for the Management of Childhood Non-B Acute Lymphoblastic Leukemia","status":"UNKNOWN","sponsor":"University Hospital, Motol","isPivotal":true,"enrollment":4000,"indication":"Leukemia","completionDate":""},{"nctId":"NCT06486337","phase":"Phase 2","title":"A Single-arm, Multi-center, Prospective Clinical Study of Mitoxantrone Hydrochloride Liposome Injection-based CMOP±R Regimen in the Treatment of Newly Diagnosed Non-Hodgkin's Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","isPivotal":false,"enrollment":197,"indication":"NHL","completionDate":"2027-08-31"},{"nctId":"NCT01528085","phase":"Phase 2","title":"An Open Label Phase II Study to Evaluate the Efficacy and Safety of Induction and Consolidation Therapy With Nilotinib in Combination With Chemotherapy in Patients Aged 55 Years and Over With Philadel","status":"COMPLETED","sponsor":"Goethe University","isPivotal":false,"enrollment":79,"indication":"Philadelphia Chromsome Positive Acute Lymphoblastic Leukemia","completionDate":"2020-03-10"},{"nctId":"NCT03631862","phase":"Phase 4","title":"A Randomized Controlled Clinical Trial of Apatinib Combined With CHOP Regimen in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma","status":"UNKNOWN","sponsor":"Zhengzhou University","isPivotal":false,"enrollment":100,"indication":"Newly Diagnosed Peripheral T-cell Lymphoma","completionDate":"2019-12-31"},{"nctId":"NCT04043494","phase":"Phase 3","title":"LBL 2018 - International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma","status":"RECRUITING","sponsor":"University Hospital Muenster","isPivotal":true,"enrollment":683,"indication":"Lymphoblastic Lymphoma, Childhood","completionDate":"2027-11-22"},{"nctId":"NCT04843267","phase":"Phase 2","title":"A Multi-center, Non-randomized, Open-label Phase II Clinical Study on the Treatment of Newly Diagnosed Advanced Hodgkin's Lymphoma With PD-1 Antibody (Tislelizumab) Combined With AVD Regimen (Doxorubi","status":"UNKNOWN","sponsor":"Sun Yat-sen University","isPivotal":false,"enrollment":30,"indication":"Hodgkin Lymphoma, Chemotherapy Effect","completionDate":"2025-05-01"},{"nctId":"NCT04152577","phase":"Phase 4","title":"Lenalidomide, Rituximab and Combination Chemotherapy Versus Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Highly Aggressive Non-Hodgkin B-cell Lymphoma","status":"UNKNOWN","sponsor":"Shandong Provincial Hospital","isPivotal":false,"enrollment":200,"indication":"Lymphoma, B-Cell","completionDate":"2022-01-01"},{"nctId":"NCT00017225","phase":"Phase 2","title":"Neuroblastoma Study Phase II Study of Various Therapies in Patients With Neuroblastoma","status":"COMPLETED","sponsor":"German Society for Pediatric Oncology and Hematology GPOH gGmbH","isPivotal":false,"enrollment":0,"indication":"Neuroblastoma","completionDate":"2002-02"},{"nctId":"NCT00696735","phase":"Phase 3","title":"Randomized Phase III Study Comparison Between Conventional Chemotherapy and High-Dose Therapy Followed by Autologous Purged Stem-Cell Transplantation in Patients With Follicular Lymphoma Stage III,IV ","status":"COMPLETED","sponsor":"French Innovative Leukemia Organisation","isPivotal":true,"enrollment":172,"indication":"Follicular Lymphoma","completionDate":"2006-05"},{"nctId":"NCT06918015","phase":"Phase 2","title":"A Prospective, Single-arm, Phase II Study of Zanubrutinib in Combination With GCVP (Obinutuzumab, Cyclophosphamide, Vindesine, Prednisolone) in Previously Untreated Follicular Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"Zhejiang Cancer Hospital","isPivotal":false,"enrollment":58,"indication":"BTK Inhibitors, Follicular Lymphoma","completionDate":"2030-05-01"},{"nctId":"NCT00002532","phase":"Phase 2","title":"TREATMENT OF ADULT PATIENTS WITH RELAPSING ACUTE LYMPHOCYTIC LEUKEMIA, A MULTICENTER TRIAL","status":"UNKNOWN","sponsor":"Hannover Medical School","isPivotal":false,"enrollment":0,"indication":"Leukemia","completionDate":""},{"nctId":"NCT05933967","phase":"Phase 2","title":"A Phase II, Prospective ,Multicenter Study Evaluating the Efficacy and Safety of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With Double Expression Diffuse Large B-cell Lymphoma","status":"RECRUITING","sponsor":"Shandong Cancer Hospital and Institute","isPivotal":false,"enrollment":31,"indication":"The First Affiliated Hospital of Nanchang University","completionDate":"2026-12-30"},{"nctId":"NCT05290090","phase":"Phase 2","title":"Prospective, Single-arm, Phase II Clinical Study of Rituximab, Lenalidomide, and Zanubrutinib Combination Regimen Followed by Immunochemotherapy in the Treatment of Elderly Patients With Newly-diagnos","status":"UNKNOWN","sponsor":"Zhejiang Cancer Hospital","isPivotal":false,"enrollment":31,"indication":"Diffuse Large B Cell Lymphoma","completionDate":"2025-12-01"},{"nctId":"NCT00002802","phase":"Phase 3","title":"PHASE III MULTICENTRE TRIAL OF TREATMENT OF NEUROBLASTOMA IN CHILDREN AND ADOLESCENTS","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","isPivotal":true,"enrollment":500,"indication":"Neuroblastoma","completionDate":"2003-09"},{"nctId":"NCT01724879","phase":"Phase 2","title":"Open Label Phase II Study to Evaluate the Safety of Standard Induction and Consolidation Therapy in Combination With Dasatinib in Newly Diagnosed Adult Patients With Philadelphia Chromosome Positive A","status":"COMPLETED","sponsor":"Goethe University","isPivotal":false,"enrollment":19,"indication":"Philadelphia Positive Acute Lymphoblastic Leukemia","completionDate":"2015-09"},{"nctId":"NCT05498259","phase":"Phase 2","title":"A Phase 2 Study of Orelabrutinib With R-CHOP-like Regimen for Patients With Newly Diagnosed Untreated Non-GCB DLBCL","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Soochow University","isPivotal":false,"enrollment":46,"indication":"Diffuse Large B-Cell Lymphoma","completionDate":"2025-01-01"},{"nctId":"NCT05040555","phase":"NA","title":"A Prospective Clinical Study of R-CDOP Regimen in the Treatment of Newly Diagnosed Non-Hodgkin's Lymphoma With High Tumor Burden","status":"RECRUITING","sponsor":"oubai, MD/PhD","isPivotal":false,"enrollment":64,"indication":"Diffuse Large B Cell Lymphoma, Follicular Lymphoma Grade 3B","completionDate":"2028-09-01"},{"nctId":"NCT00613457","phase":"Phase 3","title":"AIEOP LLA 2000 Multicenter Study for the Diagnosis and Treatment of Childhood Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"Associazione Italiana Ematologia Oncologia Pediatrica","isPivotal":true,"enrollment":2039,"indication":"Leukemia","completionDate":"2006-07"},{"nctId":"NCT02987244","phase":"Phase 1","title":"Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","isPivotal":false,"enrollment":100,"indication":"T Cell Non-Hodgkin's Lymphoma","completionDate":"2023-03"},{"nctId":"NCT00003240","phase":"Phase 3","title":"A Major Randomised Trial to Determine the Value of Cisplatin-Based Chemotherapy For All Patients With Non-Small Cell Lung Cancer","status":"UNKNOWN","sponsor":"National Cancer Institute (NCI)","isPivotal":true,"enrollment":1800,"indication":"Lung Cancer","completionDate":""},{"nctId":"NCT01173887","phase":"Phase 2","title":"Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma (Untreated Primary Disease)","status":"COMPLETED","sponsor":"Kyowa Kirin Co., Ltd.","isPivotal":false,"enrollment":44,"indication":"Adult T-cell Leukemia-Lymphoma","completionDate":"2012-04"},{"nctId":"NCT06176027","phase":"Phase 1","title":"Therapeutic Effect of Chemotherapy Azacytidine Plus CAOLD Regimen on Patients With Relapsed/Refractory Peripheral T-Cell Lymphomas","status":"RECRUITING","sponsor":"Navy General Hospital, Beijing","isPivotal":false,"enrollment":52,"indication":"Relapsed Peripheral T-Cell Lymphomas, Refractory Peripheral T-Cell Lymphomas","completionDate":"2030-09-01"},{"nctId":"NCT02867566","phase":"Phase 3","title":"A Multicenter, Randomized, Double-blind, Controlled, Phase III Study to Evaluate the Efficacy and Safety of IBI301 (Recombinant Chimeric Anti-CD20 Monoclonal Antibody ) in Combination With CHOP Regime","status":"COMPLETED","sponsor":"Innovent Biologics (Suzhou) Co. Ltd.","isPivotal":true,"enrollment":420,"indication":"Diffuse, Large B-Cell, Lymphoma","completionDate":"2019-12-26"},{"nctId":"NCT06361329","phase":"Phase 3","title":"A Multicenter, Prospective, Randomized Controlled Clinical Study Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in the Treatment of Adult Newly Diagnosed Early Precursor T-cell A","status":"RECRUITING","sponsor":"First Affiliated Hospital of Zhejiang University","isPivotal":true,"enrollment":81,"indication":"ETP-ALL","completionDate":"2027-03-31"},{"nctId":"NCT04899570","phase":"Phase 2","title":"A Prospective Phase II Study of Zanubrutinib Combined With R-CHOP in Newly-diagnosed Intravascular Large B-cell Lymphoma","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","isPivotal":false,"enrollment":20,"indication":"Intravascular Large B-Cell Lymphoma","completionDate":"2025-04-01"},{"nctId":"NCT05164770","phase":"Phase 3","title":"A Multi-center, Prospective Clinical Study of Zanubrutinib, Rituximab and Combination Chemotherapy in Patients With Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma","status":"UNKNOWN","sponsor":"Shandong Provincial Hospital","isPivotal":true,"enrollment":160,"indication":"High Grade B-Cell Lymphoma, Not Otherwise Specified, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements","completionDate":"2024-12-31"},{"nctId":"NCT00410631","phase":"Phase 3","title":"NB2004 Trial Protocol for Risk Adapted Treatment of Children With Neuroblastoma","status":"UNKNOWN","sponsor":"German Society for Pediatric Oncology and Hematology GPOH gGmbH","isPivotal":true,"enrollment":642,"indication":"Neuroblastoma","completionDate":""},{"nctId":"NCT00144053","phase":"Phase 3","title":"A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lu","status":"COMPLETED","sponsor":"West Japan Thoracic Oncology Group","isPivotal":true,"enrollment":450,"indication":"Lung Cancer","completionDate":""},{"nctId":"NCT00869284","phase":"Phase 2","title":"Phase II Study Treatment of High Risk Non-Hodgkin's Lymphomas","status":"COMPLETED","sponsor":"French Innovative Leukemia Organisation","isPivotal":false,"enrollment":45,"indication":"Lymphoma","completionDate":"2009-02"},{"nctId":"NCT01156883","phase":"NA","title":"Young Adult Acute Lymphoid Leukemia (ALL): Intensification of Pediatric AIEOP LLA-2000 Treatment","status":"COMPLETED","sponsor":"Gruppo Italiano Malattie EMatologiche dell'Adulto","isPivotal":false,"enrollment":76,"indication":"Leukemia","completionDate":"2017-10-31"},{"nctId":"NCT01117441","phase":"Phase 3","title":"International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"University Hospital Schleswig-Holstein","isPivotal":true,"enrollment":6136,"indication":"Leukemia","completionDate":"2021-12-31"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Oncology"],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"genericManufacturerList":[],"modality":"Small molecule","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}